Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-724-5 | CAS number: 12027-70-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 22 April 2008 to 02 June 2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- Description: white powder
Constituent 1
Method
- Target gene:
- TK gene
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- Cell Line
The L5178Y TK+/- 3.7.2c mouse lymphoma cell line was obtained from Dr J Cole of the MRC Cell Mutation Unit at the University of Sussex, Brighton, UK. The cells were originally obtained from Dr D Clive of Burroughs Wellcome (USA) in October 1978 and were frozen in liquid nitrogen at that time.
Cell Culture
The stocks of cells are stored in liquid nitrogen at -196°C. Cells were routinely cultured in RPMI 1640 medium with Glutamax-1 and HEPES buffer (20 mM) supplemented with Penicillin (100 units/ml), Streptomycin (100 µg/ml), Sodium pyruvate (1 mM), Amphotericin B (2.5 µg/ml) and 10% donor horse serum (giving R10 media) at 37°C with 5% CO2 in air. The cells have a generation time of approximately 12 hours and were subcultured accordingly. RPMI 1640 with 20% donor horse serum (R20) and without serum (R0) are used during the course of the study.
Cell Cleansing
The TK +/- heterozygote cells grown in suspension spontaneously mutate at a low but significant rate. Before the stocks of cells were frozen they were cleansed of homozygous (TK -/-) mutants by culturing in THMG medium for 24 hours. This medium contained Thymidine (9 µg/ml), Hypoxanthine (15 µg/ml), Methotrexate (0.3 µg/ml) and Glycine (22.5 µg/ml). For the following 24 hours the cells were cultured in THG medium (i.e. THMG without Methotrexate) before being returned to R10 medium. - Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- phenobarbital/β naphthoflavone activated rat liver S9
- Test concentrations with justification for top dose:
- Concentrations used in the preliminary toxicity test (with and without metabolic activation)
0, 11.17, 22.34, 44.69, 89.38, 178.75, 357.5, 715, 1430, 2860 µg/ml
Concentrations used in the main test (with and without metabolic activation)
0, 178.75, 357.5, 715, 1430, 2145, 2860 µg/ml - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: The test material was dissolved in DMSO prior to dilution to the test concentrations.
- Justification for choice of solvent/vehicle: Not reported.
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: see "Any other information on materials and methods inc. tables" section
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in suspension
DURATION
- Preincubation period:
- Exposure duration: 4 hours (in both the presence and absence of S9) and 24hours (in the absence of S9 only)
- Expression time (cells in growth medium): 2 days
- Selection time (if incubation with a selection agent):
- Fixation time (start of exposure up to fixation or harvest of cells): 52 to 72 hours
SPINDLE INHIBITOR (cytogenetic assays): 5-trifluorothymidine (TFT)
STAIN (for cytogenetic assays): MTT
NUMBER OF REPLICATIONS: 2 per experiment
NUMBER OF CELLS EVALUATED: ca. 192000 (2000 cells/well, 96 wells)
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth - Evaluation criteria:
- For a test material to demonstrate a mutagenic response it must produce a statistically significant increase in the induced mutant frequency (IMF) over the concurrent vehicle mutant frequency value.
Following discussions at an International Workshop on Genotoxicity Test Procedures in Plymouth, UK, 2002. It was felt that the IMF must exceed some value based on the global background MF for each method (agar or microwell). This Global Evaluation Factor (GEF) value was set following a further meeting of the International Workshop in Aberdeen, Scotland, 2003 at 126 x 10.6 for the microwell method. Therefore any test material dose level that has a mutation frequency value that is greater than the corresponding vehicle control by the GEF of 126 x 10^-6 will be considered positive.
However, if a test material produces a modest increase in mutant frequency, which only marginally exceeds the GEF value and is not reproducible or part of a dose-related response, then it may be considered to have no toxicological significance. Conversely, when a test material induces modest reproducible increases in the mutation frequencies that do not exceed the GEF value then scientific judgement will be applied. If the reproducible responses are significantly dose-related and include increases in the absolute numbers of mutant colonies then they may be considered to be toxicologically significant. - Statistics:
- The experimental data was analysed using a dedicated computer program which follows the statistical guidelines recommended by the UKEMS
Calculation of % Relative Suspension Growth (%RSG)
The cell counts obtained immediately post treatment and over the 2-day expression period were used to calculate the % Relative Suspension Growth.
Suspension Growth (SG) = (24-hour cell count/2) x (48-hour cell count/2)
Day 0 Factor = dose 0-hour cell count/vehicle control 0-hour cell count
%RSG = [(dose SG x dose Day 0 Factor)/vehicle control SG] x 100
Calculation of Plating Efficiency (PE)
Since the distribution of colony-forming units over the wells is described by the Poisson distribution, the plating efficiency (PE), from which is derived the viability (%V), was calculated using the zero term of the Poisson distribution [P(0)] method.
P(0) = number of negative wells/total wells plated
PE% = -ln P(0) x 100/number of cells per well
Calculation of Relative Total Growth (RTG)
For each culture, the relative cloning efficiency, RCE, was calculated:
RCE = PE/Mean Solvent Control PE x 100%
Finally, for each culture RTG is calculated:
RTG = (RCE x RSG)/100%
Calculation of Mutation Frequency (MF)
MF per survivor = [(-ln P(0) selective medium)/cells per well in selective medium)]/surviving fraction in non-selective medium.
Results and discussion
Test results
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- The maximum dose level used was the 10 mM limit dose. A precipitate of test material was observed at and above 178.75 µg/ml. The vehicle (solvent) controls had acceptable mutant frequency values that were within the normal range for the L5178Y cell line at the TK +/- locus. The positive control materials induced marked increases in the mutant frequency indicating the satisfactory performance of the test and of the activity of the metabolising system.
The test material did not induce any toxicologically significant increases in the mutant frequency at any dose level, either with or without metabolic activation, in either the first or the second experiment using a dose range that included the 10 mM limit dose. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Experiment 1 |
|||||||
Treatment (µg/ml) |
4-Hours-S9 |
Treatment (µg/ml) |
4-Hours +S9 |
||||
%RSG |
RTG |
MF§ |
%RSG |
RTG |
MF§ |
||
0 |
100 |
1 |
148.68 |
0 |
100 |
1 |
195.82 |
178.75 |
111 |
1.06 |
159.2 |
178.75 |
123 |
1.24 |
160.01 |
357.5 |
106 |
1.16 |
157.24 |
357.5 |
108 |
1.16 |
132.92 |
715 |
94 |
1 |
209.65 |
715 |
109 |
1.18 |
173.12 |
1430 |
80 |
0.95 |
132.72 |
1430 |
103 |
1.19 |
154.93 |
2145 |
72 |
0.81 |
111.64 |
2145 |
97 |
0.98 |
168.36 |
2860 |
71 |
0.75 |
108.05 |
2860 |
102 |
1.26 |
164.29 |
Linear trend |
NS |
Linear trend |
NS |
||||
EMS |
CP |
||||||
400 |
83 |
0.6 |
646.27 |
0 |
61 |
0.27 |
992.73 |
Experiment 2 |
|||||||
Treatment (µg/ml) |
24-Hours-S9 |
Treatment (µg/ml) |
4-Hours +S9 |
||||
%RSG |
RTG |
MF§ |
%RSG |
RTG |
MF§ |
||
0 |
100 |
1 |
86.16 |
0 |
100 |
1 |
102.03 |
178.75 |
144 |
1.18 |
76.1 |
178.75 |
122 |
1.17 |
69.1 |
357.5 |
157 |
1.34 |
65.37 |
357.5 |
116 |
1.05 |
93.45 |
715 |
150 |
1.19 |
100.71 |
715 |
105 |
1.21 |
73.23 |
1430 |
154 |
0.99 |
116.97 |
1430 |
97 |
1 |
79.94 |
2145 |
154 |
1.33 |
102.07 |
2145 |
102 |
0.94 |
82.48 |
2860 |
159 |
1.24 |
107.49 |
2860 |
91 |
0.99 |
69.77 |
Linear trend |
* |
Linear trend |
NS |
||||
EMS |
CP |
||||||
150 |
83 |
0.48 |
918.42 |
0 |
57 |
0.33 |
599.73 |
%RSG = Relative Suspension Growth
RTG = Relative Total Growth
CP = Cyclophosphamide
EMS = Ethylmethanesulphonate
MF§ = 5-TFT resistant mutants/10^6 viable cells 2 days after treatment
* = p<0.05
NS = Not significant
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative Negative, both in the presence and absence of metabolic activation
The test material did not induce any toxicologically significant increases in the mutant frequency at the TK +/- locus in L5178Y cells and is therefore considered to be non-mutagenic under the conditions of the test. - Executive summary:
In a mammalian cell gene mutation assay performed in accordance with OECD Guidelines for the testing of chemicals No. 476 and EU method B17, TK +/- locus, L5178Y cells cultured in vitro were exposed to the test material at concentrations of up to 2860 µg/mL (10 mM limit dose) in both the presence and absence of mammalian metabolic activation
The positive controls induced the appropriate response. The test material did not induce any toxicologically significant increases in the mutant frequency at the TK +/- locus in L5178Y cells and is therefore considered to be non-mutagenic under the conditions of the test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Although ECHA is providing a lot of online material in your language, part of this page is only in English. More about ECHA’s multilingual practice.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
the-echa-website-uses-cookies
find-out-more-on how-we-use-cookies